source
- Veradermics reports positive late-stage results for oral hair-loss pill VDPHL01Veradermics announced that its experimental oral medication VDPHL01 met its primary goals in a Phase 3 trial for male pattern hair loss. Over six months, participants taking the drug once or twice…
- Revolution Medicines threatens lawsuit against Erasca over RAS drug patent and efficacy claimsEarlier this month a newly announced cancer therapy generated strong interest from patients and investors. The drug, which targets the RAS pathway, was highlighted for its potential impact on oncol…